Recent Quotes (30 days)

You have no recent quotes
chg | %

GlaxoSmithKline plc news

   Watch this stock
Showing stories 21 - 30 of about 169   

Articles published

GSK 1,378.50 +31.50 (2.34%)
price chart
GlaxoSmithKline plc Receives Average Rating of �Hold� from Analysts (NYSE ...
GlaxoSmithKline plc logo GlaxoSmithKline plc (NYSE:GSK) has earned an average rating of �Hold� from the twenty-four ratings firms that are covering the stock, Stock Ratings Network.
Healthcare Sector Movers: Merck & Co. Inc. (MRK), GlaxoSmithKline plc (GSK ...
GlaxoSmithKline plc (GSK) of the Healthcare sector (Drug Manufacturers - Major) moved by 0.83% since open at mid-day today.
Related articles »  
GlaxoSmithKline plc Earns "Neutral" Rating from JPMorgan Chase & Co. (GSK)
JPMorgan Chase & Co. reissued their neutral rating on shares of GlaxoSmithKline plc (NYSE:GSK) in a research report sent to investors on Tuesday morning.
GlaxoSmithKline Plc share price down, to eliminate 900 positions in the US ...
According to the Financial Times, the 23 analysts offering 12-month price targets for GlaxoSmithKline Plc have a median target of GBX1 530, with a high estimate of GBX1 758 and a low estimate of GBX1 250.
GlaxoSmithKline plc Receives Consensus Recommendation of �Hold� from ...
GlaxoSmithKline plc logo GlaxoSmithKline plc (LON:GSK) has earned a consensus recommendation of �Hold� from the twenty-four ratings firms that are currently covering the stock, American Banking and Market News reports.
Biotech Morning Shines with AstraZeneca PLC (NYSE:AZN), Sanofi (NYSE:SNY ...  StreetWise Report
Travis Perkins plc Price Target Increased to GBX 1800 by Analysts at Morgan ...  WKRB News
Related articles »  
Closing Bell News Buzz: 3D Systems Corporation (DDD), GlaxoSmithKline plc ...
GlaxoSmithKline plc (GSK) of the Healthcare sector (Drug Manufacturers - Major) closed the day at $42.04 gaining 0.29%, a change from open of 0.31% with a volume of 4,108,664 shares.
Related articles »  
GlaxoSmithKline Ebola Vaccine Found Safe in Early Tests
GlaxoSmithKline Plc (GSK)'s Ebola vaccine produced responses from the immune system and didn't raise safety concerns in a study with 20 healthy adults, completing an initial step toward making it widely available.
Major Ebola Breakthrough As GlaxoSmithKline (GSK) Reports Promising ...  Bidness ETC
Related articles »  
GlaxoSmithKline plc Earns Hold Rating from Jefferies Group (GSK)
Receive News & Ratings for GlaxoSmithKline plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GlaxoSmithKline plc and related companies with Analyst Ratings Network's FREE daily ...
GlaxoSmithKline plc's Overweight Rating Reaffirmed at Morgan Stanley (GSK)  Intercooler
GlaxoSmithKline plc Receives Overweight Rating from Morgan Stanley (GSK)  Watch List News (press release)
Related articles »  
Pharma Equities Technical Analysis -- GlaxoSmithKline, Bristol-Myers Squibb ...
Investor-Edge has initiated coverage on the following equities: GlaxoSmithKline PLC (NYSE: GSK), Bristol-Myers Squibb Company (NYSE: BMY), Teva Pharmaceutical Industries Ltd (NYSE: TEVA), Endo International PLC (NASDAQ: ENDP), and Allergan Inc.
Related articles »  
Bank of America Lowers GlaxoSmithKline plc to Underperform (GSK)
Bank of America downgraded shares of GlaxoSmithKline plc (NYSE:GSK) from a neutral rating to an underperform rating in a research note released on Tuesday morning.